Simplifying Global Compliance
US FDA Allows More Time to Comment on Proposed Rule for Combo Products
International Medical Device Regulatory Monitor
At the request of stakeholders, the U.S. Food and Drug Administration (FDA) has extended the comment period to Feb. 5 on a proposed rule on good manufacturing
practices (GMPs) for combination products.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing